Skip to content
AwardedFinlandGoods

Nusinerseenivalmisteen (Spinraza) suorahankinta

Published
Published 18 March 2026

Overview

Nusinerseenivalmiste Spinraza 12 mg, 28 mg ja 50 mg -injektionesteet (ATC-koodi M09AX07) kromosomiin 5q liittyvän spinaalisen lihasatrofian hoitoon.

Key details

Country
Finland
Status
Awarded
Category
Goods
Procedure
Direct
Published
18 March 2026
Classification (CPV)
Medical equipments, pharmaceuticals and personal care products

Award outcome

Awarded value
€650,000
Award date
8 April 2026
Contract period
1 April 2026 → 31 December 2027
Winner
  • Biogen Finland Oy

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 April 2026

  2. Contract Notice

    18 March 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Nusinerseenivalmisteen (Spinraza) suorahankinta — won by Biogen Finland Oy — Skim